Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kai-Cheng Chang
Letter: Contraindicated Drug-Drug Interactions Before and After Initiation of Direct-Acting Anti-Viral Agents in Chronic Hepatitis C Patients in Taiwan
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Sodium Glucose Co-Transporter 2 Inhibitors and Cardiovascular Event Protections: How Applicable Are Clinical Trials and Observational Studies to Real-World Patients?
BMJ Open Diabetes Research and Care
Endocrinology
Metabolism
Diabetes
Related publications
Letter: Contraindicated Drug-Drug Interactions Before and After Initiation of Direct-Acting Anti-Viral Agents in Chronic Hepatitis C Patients in Taiwan. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Comorbidities, Concomitant Medications, and Potential Drug-Drug Interactions With Interferon-Free Direct-Acting Anti-Viral Agents in Chronic Hepatitis C
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Comorbidities, Concomitant Medications and Potential Drug-Drug Interactions With Interferon-Free Direct-Acting Anti-Viral Agents in Chronic Hepatitis C - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Hepatitis B Virus Reactivation in Patients With Chronic Hepatitis C During Direct-Acting Anti-Viral Therapy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
The Majority of Hepatitis C Patients Treated With Direct Acting Antivirals Are at Risk for Relevant Drug-Drug Interactions
United European Gastroenterology Journal
Oncology
Gastroenterology
Letter: Chronic Hepatitis C Genotype 3 Infection - Still a Hurdle Toward a Direct-Acting Anti-Viral-Induced HCV Cure?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Low Rates of HBV Serology Testing in Patients With Chronic Hepatitis C Receiving Direct Acting Antivirals
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Short-Term Risk of Hepatocellular Carcinoma After Hepatitis C Virus Eradication Following Direct-Acting Anti-Viral Treatment
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
